ELVN
Enliven Therapeutics Inc.
47.00$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.0% | 97.9% | 98.4% | 97.3% | 97.2% | 97.7% | 97.3% | 98.4% | 98.3% | 99.7% | 99.6% | 99.7% | |
| 26.9% | 36.8% | 43.5% | 29.6% | 32.9% | 38.1% | 33.6% | 23.7% | 20.7% | 20.8% | 28.4% | 14.9% | |
| 96.1% | 93.1% | 93.5% | 95.5% | 95.5% | 96.2% | 95.7% | 97.3% | 97.3% | 97.2% | 97.3% | 98.3% | |
| 4.5% | 9.5% | 7.3% | 6.8% | 5.6% | 4.9% | 4.7% | 3.1% | 3.0% | 3.5% | 2.5% | 1.7% | |
| 4.4% | 9.5% | 7.3% | 6.8% | 5.6% | 4.9% | 4.6% | 3.0% | 3.0% | 3.5% | 2.5% | 1.6% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | – | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 0.5% | 0.2% | 0.8% | 0.3% | 0.3% | 0.4% | 0.5% | 0.5% | 0.3% | 0.5% | 0.4% | 0.0% | |
| 95.5% | 90.5% | 92.7% | 93.2% | 94.4% | 95.1% | 95.3% | 96.9% | 97.0% | 96.5% | 97.5% | 98.3% | |
| -49.3% | -56.8% | -51.7% | -60.3% | -72.1% | -74.7% | -89.9% | -59.0% | -64.7% | -72.9% | -79.8% | -44.3% | |
| 15.0% | 15.1% | 12.3% | 14.7% | 15.8% | 15.3% | 16.5% | 10.3% | 12.6% | 11.9% | 13.5% | 7.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.